Tracheoesophageal Fistula Following Chemoradiation and Esophagectomy in Esophageal Adenocarcinoma: A Fatal Complication.

Document Type

Article

Publication Date

7-6-2025

Publication Title

Cureus

Abstract

Tracheoesophageal fistula (TEF) is a rare but devastating complication that can arise in patients with esophageal cancer following multimodal therapy. We present the case of a 45-year-old male with stage III esophageal adenocarcinoma treated with neoadjuvant chemoradiation, followed by esophagectomy and immunotherapy. He subsequently developed a large TEF, resulting in recurrent aspiration, bleeding, and ultimately death despite comprehensive supportive measures. TEFs are associated with significant morbidity and mortality, and current therapeutic strategies remain limited. However, promising advances in endoscopic modalities and reconstructive surgery are emerging. Management necessitates a multidisciplinary, individualized approach, although standardized guidelines are currently lacking. Our case underscores the need for vigilance in patients at risk for TEF and the critical importance of early diagnosis and tailored intervention to prevent life-threatening complications.

Volume

17

Issue

7

First Page

e87394

DOI

10.7759/cureus.87394

ISSN

2168-8184

PubMed ID

40625666

Link to Full Text

Share

COinS